Indonesia vs Liberia: Previously treated cases tested for RR-/MDR-TB
Indonesia
83.0%
in 2024
Liberia
83.0%
in 2024
Indonesia rank
104th
Liberia rank
104th
Previously treated cases tested for RR-/MDR-TB over time
- Indonesia
- Liberia
How they compare
Indonesia currently reports 83.0% against 83.0% in Liberia, a difference of 0.0%.
The two have swapped places 5 times across 12 shared years of data; in 2010 it was Indonesia ahead.
Indonesia ranks 104th and Liberia ranks 104th of 180 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 74.7% | 53.9% | 20.8% | Indonesia |
| 2020s | 84.4% | 47.6% | 36.8% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Indonesia or Liberia?
- Indonesia, at 83.0% against 83.0% in Liberia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Indonesia and Liberia?
- 0.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Liberia?
- 12 years are reported by both, from 2010 to 2024.
- How do Indonesia and Liberia rank globally for previously treated cases tested for rr-/mdr-tb?
- Indonesia ranks 104th and Liberia ranks 104th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.